A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors.
Sonehara K, Kimura Y, Nakano Y, Ozawa T, Takahashi M, Suzuki K, Fujii T, Matsushita Y, Tomiyama A, Kishikawa T, Yamamoto K, Naito T, Suzuki T, Yamaguchi S, Miwa T, Sasaki H, Kitagawa M, Ohe N, Fukai J, Ogiwara H, Kawamura A, Miyawaki S, Matsuda F, Kiyokawa N, Ichimura K, Nishikawa R, Okada Y, Terashima K.
Sonehara K, et al. Among authors: kimura y.
Nat Commun. 2022 Aug 2;13(1):4478. doi: 10.1038/s41467-022-32005-9.
Nat Commun. 2022.
PMID: 35918310
Free PMC article.